Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
Related Questions
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
What is your preferred management for renal artery thrombosis causing renal infarct of unclear etiology?
Do you routinely evaluate for PE if a DVT is found?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
For patients with a history of pregnancy loss, do you evaluate for PAI-1 polymorphisms as part of a thrombophilia workup?
How often do you check weight and adjust anticoagulation dosing in pregnancy?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
